Pharmacokinetic (PK) and exposure-response (ER) analysis of pertuzumab (P) in patients (pts) with HER2-positive metastatic gastroesophageal junction and gastric cancer (mGEJC/GC).

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorKIRSCHBROWN, Whitney Paige
dc.contributor.authorWANG, Bei
dc.contributor.authorNIJEM, Ihsan
dc.contributor.authorOHTSU, Atsushi
dc.contributor.authorHOFF, Paulo M.
dc.contributor.authorSHAH, Manish A.
dc.date.accessioned2019-01-29T17:08:41Z
dc.date.available2019-01-29T17:08:41Z
dc.date.issued2018
dc.description.indexMEDLINEeng
dc.identifier.citationJOURNAL OF CLINICAL ONCOLOGY, v.36, n.15, suppl.S, 2018
dc.identifier.doi10.1200/JCO.2018.36.15_suppl.2564
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/30453
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGYeng
dc.relation.ispartofJournal of Clinical Oncology
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright AMER SOC CLINICAL ONCOLOGYeng
dc.subject.wosOncologyeng
dc.titlePharmacokinetic (PK) and exposure-response (ER) analysis of pertuzumab (P) in patients (pts) with HER2-positive metastatic gastroesophageal junction and gastric cancer (mGEJC/GC).eng
dc.typeconferenceObjecteng
dc.type.categorymeeting abstracteng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.contributor.author-fmusphcPAULO MARCELO GEHM HOFF
hcfmusp.description.issue15
hcfmusp.description.issuesuppl S
hcfmusp.description.volume36
hcfmusp.origemWOS
hcfmusp.origem.wosWOS:000442916001343
hcfmusp.publisher.cityALEXANDRIAeng
hcfmusp.publisher.countryUSAeng
relation.isAuthorOfPublication706efa42-09fc-4065-8330-9391f2cbe840
relation.isAuthorOfPublication.latestForDiscovery706efa42-09fc-4065-8330-9391f2cbe840
Arquivos
Coleções
Comunicações em Eventos - FM/MDR
Comunicações em Eventos - LIM/24